You are here

Biomarkers for the prediction of persistent post-concussion symptoms after mild traumatic brain injury

Description 
Although most individuals with a mild traumatic brain injury (mTBI) are symptom-free after 1-2 weeks, around 20% experience debilitating persistent post-concussion symptoms (PPCS) that last for several weeks or longer. A major challenge for clinicians is predicting the ~20% who will experience PPCS. Discovery of a prognostic biomarker for PPCS would allow clinicians to identify which patients require increased monitoring and interventions to improve recovery. In this study, in an ongoing collaboration with Prof. Biswadev Mitra, Director of Emergency Medicine Research at The Alfred, we will recruit mTBI and control patients through The Alfred Hospital Emergency Department, and investigate how novel blood tests might be used to predict patients with PPCS.
Essential criteria: 
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords 
Concussion, biomarker, mild traumatic brain injury, neuropsychological testing, physiology, neuroscience, pathology
School 
Central Clinical School » Neuroscience
Available options 
PhD/Doctorate
Masters by research
Honours
BMedSc(Hons)
Time commitment 
Full-time
Top-up scholarship funding available 
No
Physical location 
Alfred Centre, The Alfred Hospital
Co-supervisors 
Prof 
Biswadev Mitra
Assoc Prof 
Sandy Shultz

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.